ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,525, issued on Oct. 28, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"IL4I1 inhibitors and methods of use" was invented by Brandon D. Cash (Natick, Mass.), Wenlang Fu (Madison, N.J.), George Madalin Giambasu (Natick, Mass.), Andrew M. Haidle (Somerville, Mass.), Brett A. Hopkins (Brownsburg, Ind.), Matthew A. Larsen (Templeton, Calif.), Charles A. Lesburg (Waban, Mass.), Ping Liu (Westfield, N.J.), Meredeth A. Mcgowan (Boston), Qinglin Pu (Needham, Mass.), Sulagna Sanyal (Belmont, Mass.), Phieng Siliphaivanh (Newton, Mass.), Catherine M. White (Canton, Mass.) and Xin Yan (Newton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Descri...